Dr. Cory Perugino shares how IgG4-RD’s often symptomless presentation complicates the relationship between doctor and patient, and requires proactivity from doctors.
Transcript
IgG4-related disease is a little unusual among autoimmune or rheumatologic diseases in that it has a higher propensity for asymptomatic disease activity—meaning it may not clearly cause symptoms.
As doctors, we often focus on being as good of listeners as possible. My general mantra is that the longer I sit with a patient, eventually they’ll tell me what’s going on with them right now—what’s occurring with their disease or what their disease is.
With IgG4-related disease, there’s a bit of a flip in the paradigm because the disease can be asymptomatic. A large percentage of cases are picked up incidentally, when we’re not otherwise looking for them, on a CAT scan or MRI—and they aren’t causing problems.
So, being a patient with this disease entails taking on an important listening role. It’s a bit of a flip in the paradigm. The listening aspect means forming a team with your health care provider and asking—or listening to the dialogue about—how best to monitor the disease over time.
Monitoring IgG4-related disease is important. Each health care provider—whether a rheumatologist, gastroenterologist, or someone else—may have a slightly different approach, but monitoring generally entails regular visits for physical exams and history-taking, blood work at a similar frequency, and periodic imaging.
It’s important for patients to understand what that monitoring plan looks like and to take part in making sure the screening measures are done. That’s the counterpoint to relying on “Well, I feel fine, so everything’s OK.”
It’s similar to hypertension: people often feel well even when their blood pressure is high, until one day they have a heart attack that might have been preventable.
Patients with IgG4-related disease have an important role in understanding how best to monitor the disease over time. This is a challenge for providers, too, because the disease can be asymptomatic and insidious, making it different and more challenging than other autoimmune diseases.